Univariate analysis | Multivariable analysis | ||
---|---|---|---|
p value | p value | OR, (95% CI) | |
Initial T stage (≤T2 vs ≥ T3) | 0.02 | 0.50 | 1.43 (0.50–4.11) |
Initial N stage (N0 vs N1) | 0.07 | 0.07 | 3.75 (0.89–15.81) |
Initial PSA level in ng/ml (≤20 vs > 20) | 0.36 | ||
PSA nadir after RP (≤0.07 ng/mL vs > 0,07 ng/mL) | 0.04 | 0.14 | 2.24 (0.78–6.45) |
Number of removed LN at RP (≤15 vs > 15) | 0.32 | ||
Initial Risk Group (intermediate+high risk vs. very high risk) | 0.15 | ||
PSA doubling time (≤6 months, > 6 months) | 0.46 | ||
Radiotherapy type (CF-RT vs. SBRT) | 0.11 | ||
No. of irradiated metastases (1 vs > 1) | 0.37 | ||
Type of metastases (lymph node vs bone) | 0.18 | ||
Concurrent ADT (yes vs no) | 0.03 | 0.01 | 7.86 (1.51–40.79) |
RT-Dose (≤50 Gy vs > 50 Gy) | 0.74 |